Robert Drolet is a Senior Principal Scientist at Merck, focusing on preclinical programs in neurodegenerative diseases and translational biomarker development. They previously served as a Principal Scientist and Associate Principal Scientist at Merck, leading projects in biomarker discovery and small molecule drug development for Alzheimer’s and Parkinson’s diseases. Earlier in their career, Robert conducted research as a Post-doctoral Researcher at the University of Pittsburgh, investigating the pathology of Parkinson's disease. Robert holds a PhD in Neuroscience from Michigan State University and a B.S. in Neuroscience from Central Michigan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices